FFL
BIIB icon

Financial Freedom LLC’s Biogen BIIB Stock Holding History

Financial Freedom LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.17K Hold
50
– – ﹤0.01% 310
2025
Q4 		$8.8K Hold
50
– – ﹤0.01% 276
2025
Q3 		$7K Hold
50
– – ﹤0.01% 290
2025
Q2 		$6.28K Hold
50
– – ﹤0.01% 298
2025
Q1 		$6.84K Hold
50
– – ﹤0.01% 301
2024
Q4 		$7.65K Hold
50
– – ﹤0.01% 293
2024
Q3 		$9.69K Hold
50
– – 0.01% 275
2024
Q2 		$11.6K Hold
50
– – 0.01% 263
2024
Q1 		$10.8K Hold
50
– – 0.01% 266
2023
Q4 		$12.9K Buy
+50
New +$12.3K 0.01% 252

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Freedom LLC's BIIB Position: Q1 2026 in Review

Financial Freedom LLC held its Biogen (BIIB) position steady in Q1 2026 at 50 shares worth $9.17K. The position accounts for ﹤0.01% of the portfolio, ranked #310.

Financial Freedom LLC first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.9K in Q4 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Financial Freedom LLC held 50 shares of Biogen worth $9.17K as of Q1 2026.
  • Financial Freedom LLC left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #310 holding.
  • Financial Freedom LLC first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • Financial Freedom LLC's Biogen position peaked at $12.9K in Q4 2023.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.